Immunome (IMNM) Research & Development: 2023-2025
Historic Research & Development for Immunome (IMNM) over the last 3 years, with Sep 2025 value amounting to $49.2 million.
- Immunome's Research & Development rose 32.24% to $49.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $174.4 million, marking a year-over-year increase of 91.05%. This contributed to the annual value of $129.5 million for FY2024, which is 461.06% up from last year.
- Latest data reveals that Immunome reported Research & Development of $49.2 million as of Q3 2025, which was up 21.61% from $40.5 million recorded in Q2 2025.
- In the past 5 years, Immunome's Research & Development registered a high of $49.2 million during Q3 2025, and its lowest value of $3.8 million during Q3 2023.
- Over the past 3 years, Immunome's median Research & Development value was $29.1 million (recorded in 2024), while the average stood at $25.4 million.
- Data for Immunome's Research & Development shows a peak YoY surged of 873.06% (in 2024) over the last 5 years.
- Over the past 3 years, Immunome's Research & Development (Quarterly) stood at $9.6 million in 2023, then spiked by 396.94% to $47.9 million in 2024, then skyrocketed by 32.24% to $49.2 million in 2025.
- Its Research & Development stands at $49.2 million for Q3 2025, versus $40.5 million for Q2 2025 and $36.9 million for Q1 2025.